FDA Plans Public Workshop to Evaluate Studies of Abuse-Deterrent Opioid Use

Drug Industry Daily
The FDA is planning a public workshop in July to evaluate the impact of abuse-deterrent formulations of opioid painkillers, and to find ways to better inform the agency’s regulatory approach, following recently renewed calls to action.

To View This Article:


Subscribe To Drug Industry Daily